H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas

Conditions

• Diffuse Intrinsic Pontine Glioma
• Glioma
• Diffuse Midline Glioma, H3 K27M-Mutant

Interventions

• BIOLOGICAL: K27M peptide
• DRUG: Nivolumab

Sponsor

Sabine Mueller, MD, PhD

Collaborators

• [object Object]
• [object Object]
• [object Object]